De Novo Heterogeneous Mutations in SCN2A and GRIN2A Genes and Seizures With Ictal Vocalizations.
Tulane University School of Medicine, New Orleans, LA, USA dsingh@tulane.edu.
Dinesh
D
Singh
Tulane University School of Medicine, New Orleans, LA, USA.
Monica
M
Lau
Tulane University School of Medicine, New Orleans, LA, USA.
Travis
T
Ayers
Tulane University School of Medicine, New Orleans, LA, USA.
Yashna
Y
Singh
Tulane University School of Medicine, New Orleans, LA, USA.
Olugbenga
O
Akingbola
Tulane University School of Medicine, New Orleans, LA, USA.
Lisa
L
Barbiero
Tulane University School of Medicine, New Orleans, LA, USA.
Stephen
S
Nelson
D000927:Anticonvulsants / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004569:Electroencephalography; D005260:Female; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D000077287:Levetiracetam; D009154:Mutation / Q000235:genetics*; D062551:NAV1.2 Voltage-Gated Sodium Channel / Q000235:genetics*; D010634:Phenobarbital / Q000627:therapeutic use; D010699:Phonation; D010889:Piracetam / Q000031:analogs & derivatives / Q000627:therapeutic use; D016194:Receptors, N-Methyl-D-Aspartate / Q000235:genetics*; D013036:Spasms, Infantile / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics*; D000077236:Topiramate
D000927:Anticonvulsants; D002998:Clonazepam; D005632:Fructose; D000077287:Levetiracetam; D062551:NAV1.2 Voltage-Gated Sodium Channel; D010634:Phenobarbital; D010889:Piracetam; D016194:Receptors, N-Methyl-D-Aspartate; D000077236:Topiramate; C568251:SCN2A protein, human